Principia Wealth Advisory’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Principia Wealth Advisory's RPRX Position: Q2 2026 in Review
Principia Wealth Advisory increased its Royalty Pharma (RPRX) stake by 27% in Q2 2026, buying an estimated $625 and bringing the position to 57 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #466.
Principia Wealth Advisory first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Principia Wealth Advisory held 57 shares of Royalty Pharma worth $3.2K as of Q2 2026.
- Principia Wealth Advisory bought 12 Royalty Pharma shares in Q2 2026, an estimated $625.
- Royalty Pharma made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #466 holding.
- Principia Wealth Advisory first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
- 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.